Stock A002390 HANDOK INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company HANDOK Inc.

Equities

A002390

KR7002390003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
13,830 KRW -.--% Intraday chart for HANDOK Inc. +3.67% -3.29%
Apr. 16 Nxera Pharma Partners with Handok c. to Distribute PIVLAZ in South Korea, MT
Apr. 15 Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for Pivlaz in South Korea CI

Business Summary

HANDOK Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. It also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.

Number of employees: 937

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical Merchandise
50.8 %
273,963 50.4 % 265,597 50.8 % -3.05%
Pharmaceutical Product
42.7 %
235,923 43.4 % 223,460 42.7 % -5.28%
Other
5.6 %
33,873 6.2 % 29,518 5.6 % -12.86%
Lease
0.8 %
- - 4,166 0.8 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.4 %
516,088 94.9 % 509,333 97.4 % -1.31%
International
2.6 %
27,671 5.1 % 13,408 2.6 % -51.54%

Managers

Managers TitleAgeSince
Jeong-Yeol Jo CEO
 Chief Executive Officer 57 -
Young-Jin Kim CEO
 Chief Executive Officer 67 83-12-31
Seong-Joon Hong DFI
 Director of Finance/CFO 59 17-04-20
Hyun-Ik Kim BRD
 Director/Board Member 62 -
Chul-Joon Kim BRD
 Director/Board Member 71 09-03-12
In-Je Hwang SAM
 Sales & Marketing 61 -
Young Kim LAW
 General Counsel 56 -
Eun-Joo Kim PRN
 Corporate Officer/Principal 54 -
Eun-Yeong Choi PRN
 Corporate Officer/Principal 55 -
Jin-Ki Baik HRO
 Human Resources Officer 66 -

Members of the board

Members of the board TitleAgeSince
Young-Jin Kim CEO
 Chief Executive Officer 67 83-12-31
Chul-Joon Kim BRD
 Director/Board Member 71 09-03-12
Hyun-Ik Kim BRD
 Director/Board Member 62 -
Won-Ho Kim BRD
 Director/Board Member 68 14-03-13
Young-Geo Seo BRD
 Director/Board Member 72 15-03-26
Jeong-Yeol Jo CEO
 Chief Executive Officer 57 -
Chang-Yul Kang BRD
 Director/Board Member 70 20-03-18
Chan-Hee Han BRD
 Director/Board Member 69 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,763,533 7,783,419 ( 56.55 %) 0 56.55 %

Shareholders

NameEquities%Valuation
Y&S International
17.69 %
2,435,290 17.69 % 26 M ₩
Young-Jin Kim
13.65 %
1,878,397 13.65 % 20 M ₩
Suk-jin Kim
5.131 %
706,211 5.131 % 7 M ₩
National Pension Service of Korea
4.662 %
641,680 4.662 % 7 M ₩
Geum-hee Kim
3.253 %
447,789 3.253 % 5 M ₩
Young-se Chae
1.181 %
162,557 1.181 % 2 M ₩
Handok Jeseok Foundation
0.9445 %
130,000 0.9445 % 1 M ₩
Yoo-hoon Chang
0.8384 %
115,395 0.8384 % 1 M ₩
Kong Shin Jin Heung Co., Ltd.
0.6268 %
86,268 0.6268 % 908 016 ₩
Dimensional Fund Advisors Ltd.
0.0765 %
10,526 0.0765 % 110 792 ₩

Holdings

NameEquities%Valuation
GENEXINE, INC.
14.57%
 6,048,534 14.57% 39,088,046 $
REZOLUTE, INC.
15.00%
 5,942,617 15.00% 15,153,673 $

Company contact information

Handok, Inc.

132 Teheran-ro Gangnam-gu

06235, Seoul

+

http://www.handok.co.kr
address HANDOK Inc.(A002390)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HANDOK INC. Stock HANDOK Inc.
-3.29% 138M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A002390 Stock
  4. Company HANDOK Inc.